Loading...
NPI 1932427648 · Brooklyn, NY · Diagnostic Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Esther Coronel is a diagnostic radiology physician provider located in Brooklyn, New York. This profile covers 9 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Esther Coronel |
| Address | 2236 Nostrand Ave |
| City | Brooklyn |
| State | NY |
| ZIP | 11210 |
| Taxonomy | Diagnostic Radiology Physician |
| NPI Enumerated | May 6, 2010 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.3M |
| Medicaid | $162.2K |
This provider’s billing mix is highly specialized toward PET/CT imaging and diagnostic radiopharmaceuticals. The top Medicare codes are 78815 (PET/CT), A9595 (piflufolastat f-18), and A9552 (fluorodeoxyglucose f-18 fdg), and those radiology/nuclear medicine services dominate the revenue profile rather than general office or lab work. The concentration of these imaging and radiotracer codes signals an operation organized around advanced oncologic and functional imaging studies rather than primary care or routine laboratory services.
Medicare revenue is heavily concentrated in a handful of procedures: the precomputed top 3 Medicare codes account for 97.0% of this provider’s total Medicare revenue. Individually, 78815 accounts for 59.5% of Medicare revenue (1.3K claims, $1537 avg paid/claim, $1.9M revenue), A9595 accounts for 23.8% (1.6K claims, $486 avg paid/claim, $778.6K revenue), and A9552 accounts for 13.6% (1.1K claims, $418 avg paid/claim, $445.6K revenue), underscoring a narrow set of high-value services that drive nearly all Medicare receipts.
Medicaid billing mirrors the Medicare service mix but at a much smaller scale and different unit payments: the precomputed top 3 Medicaid codes account for 100.0% of this provider’s total Medicaid revenue. On Medicaid the same imaging codes dominate—78815 represents 76.6% of Medicaid revenue (573 claims, $217 avg paid/claim, $124.3K revenue) and A9552 represents 23.4% (448 claims, $85 avg paid/claim, $38.1K revenue)—indicating the provider bills similar PET imaging services to both payers, but Medicaid contributes a much smaller share of dollars.
Payer mix is Medicare-dominant: total Medicare revenue is $3.3M compared with total Medicaid revenue of $162.2K, so while the provider participates in both programs it is effectively scaled around Medicare as the primary revenue source. This asymmetry suggests strategic reliance on Medicare volume and rates for sustaining the practice rather than on Medicaid.
National competitive standing on Medicare shows very high relative volume for PET and radiotracer codes. 78815 ranks #13 of 6566 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), A9595 ranks #9 of 528 providers nationally (98th percentile; notably above typical national volume for this code), and A9552 ranks #9 of 2411 providers nationally (100th percentile; extreme outlier), which collectively positions the provider as a major national operator for these specialized PET services.
In-state competitive standing on Medicaid is more modest: 78815 ranks #20 of 109 providers in-state (82th percentile; typical, unremarkable volume) and A9552 ranks #18 of 72 providers in-state (76th percentile; typical, unremarkable volume). Those ranks indicate the provider is a regular participant in the state market for PET imaging but not an extreme outlier on Medicaid the way it is on Medicare.
The provider’s NPI tenure is long-standing: NPI enumerated (registered) on 2010-05-06 (~16 years ago). Combined with consistently high national ranks on Medicare PET codes, this tenure supports the interpretation of an established PET/CT and nuclear medicine practice rather than a newly formed operation.
Billing-level nuance highlights both scale and payer-rate differences: 78815 generates 1.3K Medicare claims at $1537 avg paid/claim versus 573 Medicaid claims at $217 avg paid/claim, illustrating large differences in per-claim reimbursement between payers even as the same clinical services are billed. The dataset’s statistical labels (e.g., “extreme outlier” for several national Medicare ranks and “notably above typical” for others) should be read as indicators of unusually high volume relative to peers rather than as any clinical or regulatory judgment.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
9 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 1,260 | $1,540 | $1.9M |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 1,600 | $490 | $778.6K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,070 | $420 | $445.6K |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 1,840 | $50 | $93.6K |
| 82947 | The lab analyst performs a test to measure the amount of glucose in a patient's blood using a method other than a reagent strip. | 980 | $1 | $3.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 150 | $10 | $1.2K |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 10 | $20 | $260 |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 20 | $10 | $140 |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 10 | $10 | $110 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 570 | $220 | $124.3K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 450 | $90 | $38.1K |
| 82947 | The lab analyst performs a test to measure the amount of glucose in a patient's blood using a method other than a reagent strip. | 40 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 20 | 110 | 80 | $570 | $236.2K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | 70 | 90 | $150 | $72.3K |
| 82947 | The lab analyst performs a test to measure the amount of glucose in a patient's blood using a method other than a reagent strip. | 275 | 340 | 430 | $1 | $4.1K |
Other providers in the same ZIP code as Esther Coronel, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.